Literature DB >> 8388828

Attenuation and reversion of the Sabin vaccine strains of poliovirus.

P D Minor1.   

Abstract

Studies of the molecular basis of the attenuation and reversion of the attenuated phenotype of the Sabin vaccine strains suggest that few mutations are involved. It is striking that mutations in the 5' non-coding region within a 10 base region implicated in a base pair structure have been identified in all the Sabin vaccine strains. The mutations have effects on in vitro phenotypes which have implications for the production of vaccines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388828

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  16 in total

1.  Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001.

Authors:  Hiroyuki Shimizu; Bruce Thorley; Fem Julia Paladin; Kerri Anne Brussen; Vicki Stambos; Lilly Yuen; Andi Utama; Yoshio Tano; Minetaro Arita; Hiromu Yoshida; Tetsuo Yoneyama; Agnes Benegas; Sigrun Roesel; Mark Pallansch; Olen Kew; Tatsuo Miyamura
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Impaired binding of standard initiation factors mediates poliovirus translation attenuation.

Authors:  Kerstin Ochs; Amandus Zeller; Lanja Saleh; Gergis Bassili; Yutong Song; Anja Sonntag; Michael Niepmann
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.

Authors:  Joseph G Victoria; Chunlin Wang; Morris S Jones; Crystal Jaing; Kevin McLoughlin; Shea Gardner; Eric L Delwart
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

4.  Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.

Authors:  S M Smith; R B Markham; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

5.  Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Authors:  E Stadnick; M Dan; A Sadeghi; J K Chantler
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.

Authors:  J U Igietseme; A Murdin
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

7.  A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.

Authors:  William P Halford; Ringo Püschel; Edward Gershburg; Andrew Wilber; Svetlana Gershburg; Brandon Rakowski
Journal:  PLoS One       Date:  2011-03-11       Impact factor: 3.240

8.  High diversity of poliovirus strains isolated from the central nervous system from patients with vaccine-associated paralytic poliomyelitis.

Authors:  M M Georgescu; F Delpeyroux; M Tardy-Panit; J Balanant; M Combiescu; A A Combiescu; S Guillot; R Crainic
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome.

Authors:  I Leparc-Goffart; J Julien; F Fuchs; I Janatova; M Aymard; H Kopecka
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

10.  Excretion of wild-type and vaccine-derived poliovirus in the feces of poliovirus receptor-transgenic mice.

Authors:  Hein J Boot; Daniella T J Kasteel; Anne-Marie Buisman; Tjeerd G Kimman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.